{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T07:12:09Z","timestamp":1773731529189,"version":"3.50.1"},"reference-count":105,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5,1]]},"DOI":"10.2527\/jas.2015-0089","type":"journal-article","created":{"date-parts":[[2016,4,9]],"date-time":"2016-04-09T02:50:11Z","timestamp":1460170211000},"page":"1803-1811","source":"Crossref","is-referenced-by-count":11,"title":["PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Insulin action and lipotoxicity in the development of polycystic ovary syndrome: A review1"],"prefix":"10.1093","volume":"94","author":[{"given":"J.","family":"Faubert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-C.","family":"Battista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-P.","family":"Baillargeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t20180207052726_r1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/187152512800388948","article-title":"PPAR-\u03b3 agonist in treatment of diabetes: Cardiovascular safety considerations","volume":"10","author":"Abbas","year":"2012","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"key\n\t\t\t\t20180207052726_r2","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jcem.87.4.8398","article-title":"Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: Amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia\/insulin resistance","volume":"87","author":"Arslanian","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r3","first-page":"2317","article-title":"Adrenal androgen excess in the polycystic ovary syndrome: Sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis","volume":"83","author":"Azziz","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r4","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An androgen excess society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r5","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r6","first-page":"1012","article-title":"Use of insulin sensitizers in polycystic ovarian syndrome","volume":"6","author":"Baillargeon","year":"2005","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"key\n\t\t\t\t20180207052726_r8","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1007\/s00125-007-0831-9","article-title":"Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects","volume":"50","author":"Baillargeon","year":"2007","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t20180207052726_r9","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.fertnstert.2006.12.055","article-title":"Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity","volume":"88","author":"Baillargeon","year":"2007","journal-title":"Fertil. Steril."},{"key":"key\n\t\t\t\t20180207052726_r10","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity","volume":"82","author":"Baillargeon","year":"2004","journal-title":"Fertil. Steril."},{"key":"key\n\t\t\t\t20180207052726_r11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1210\/jc.2005-1804","article-title":"Commentary: Polycystic ovary syndrome: A syndrome of ovarian hypersensitivity to insulin?","volume":"91","author":"Baillargeon","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jsbmb.2009.12.010","article-title":"Insulin and hyperandrogenism in women with polycystic ovary syndrome","volume":"122","author":"Baptiste","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"key\n\t\t\t\t20180207052726_r13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.steroids.2011.12.017","article-title":"Saturated fatty acid exposure induces androgen overproduction in bovine adrenal cells","volume":"77","author":"Bellanger","year":"2012","journal-title":"Steroids"},{"key":"key\n\t\t\t\t20180207052726_r7","first-page":"95","article-title":"Insulin Resistance and Lipotoxicity in PCOS: Causes and Consequences","volume-title":"Polycystic Ovary Syndrome: Current and Emerging Concepts.","author":"Bellanger","year":"2013"},{"key":"key\n\t\t\t\t20180207052726_r14","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2337\/diacare.27.7.1660","article-title":"The effect of pioglitazone on peroxisome proliferator-activated receptor-\u03b3 target genes related to lipid storage in vivo","volume":"27","author":"Bogacka","year":"2004","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20180207052726_r15","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.mcna.2008.04.008","article-title":"Basic infertility including polycystic ovary syndrome","volume":"92","author":"Brassard","year":"2008","journal-title":"Med. Clin. North Am."},{"key":"key\n\t\t\t\t20180207052726_r16","first-page":"3914","article-title":"The angiotensin AT2 receptor is present in the human fetal adrenal gland throughout the second trimester of gestation","volume":"81","author":"Breault","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r17","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1021\/bi9821059","article-title":"Biochemical differences between rat and human cytochrome P450c17 support the different steroidogenic needs of these two species","volume":"38","author":"Brock","year":"1999","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20180207052726_r18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1462-8902.2004.00325.x","article-title":"The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes","volume":"6","author":"Buse","year":"2004","journal-title":"Diabetes Obes. Metab."},{"key":"key\n\t\t\t\t20180207052726_r19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.diabet.2007.10.009","article-title":"Postprandial fatty acid metabolism in the development of lipotoxicity and type 2 diabetes","volume":"34","author":"Carpentier","year":"2008","journal-title":"Diabetes Metab."},{"key":"key\n\t\t\t\t20180207052726_r20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2337\/diabetes.49.3.399","article-title":"Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes","volume":"49","author":"Carpentier","year":"2000","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20180207052726_r21","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/humrep\/12.9.1897","article-title":"Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome","volume":"12","author":"Ciampelli","year":"1997","journal-title":"Hum. Reprod."},{"key":"key\n\t\t\t\t20180207052726_r22","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/eje.0.1470473","article-title":"A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17alpha enzyme activity in women with polycystic ovary syndrome","volume":"147","author":"Colak","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"key\n\t\t\t\t20180207052726_r23","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2337\/diabetes.55.03.06.db05-0453","article-title":"Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome","volume":"55","author":"Corbould","year":"2006","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20180207052726_r24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"key\n\t\t\t\t20180207052726_r25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.physbeh.2010.03.018","article-title":"The renin angiotensin system and the metabolic syndrome","volume":"100","author":"de Kloet","year":"2010","journal-title":"Physiol. Behav."},{"key":"key\n\t\t\t\t20180207052726_r26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tem.2005.07.009","article-title":"Angiotensin receptors: A new role in cancer?","volume":"16","author":"Deshayes","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"Despr\u00e9s","year":"2006","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180207052726_r28","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil. Steril."},{"key":"key\n\t\t\t\t20180207052726_r29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/09513598709023614","article-title":"Adrenal cortex and type II polycystic ovary syndrome","volume":"1","author":"Devesa","year":"1987","journal-title":"Gynecol. Endocrinol."},{"key":"key\n\t\t\t\t20180207052726_r30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0889-8529(05)70073-6","article-title":"Insulin action in the polycystic ovary syndrome","volume":"28","author":"Dunaif","year":"1999","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"key\n\t\t\t\t20180207052726_r31","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20180207052726_r32","doi-asserted-by":"crossref","first-page":"E392","DOI":"10.1152\/ajpendo.2001.281.2.E392","article-title":"Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)","volume":"281","author":"Dunaif","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r33","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1172\/JCI118126","article-title":"Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome","volume":"96","author":"Dunaif","year":"1995","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20180207052726_r34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20180207052726_r35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.fertnstert.2003.05.008","article-title":"Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome","volume":"81","author":"Farah-Eways","year":"2004","journal-title":"Fertil. Steril."},{"key":"key\n\t\t\t\t20180207052726_r36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/157340212800504990","article-title":"AT2 Receptor agonists: Exploiting the beneficial arm of Ang II signaling","volume":"8","author":"Gallo-Payet","year":"2012","journal-title":"Curr. Hypertens. Rev."},{"key":"key\n\t\t\t\t20180207052726_r37","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.2337\/diabetes.53.9.2353","article-title":"Glucose intolerance in a large cohort of Mediterranean women with polycystic ovary syndrome: Phenotype and associated factors","volume":"53","author":"Gambineri","year":"2004","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20180207052726_r38","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1210\/jc.2014-3649","article-title":"Follicular fluid concentrations of lipids and their metabolites are associated with intraovarian gonadotropin-stimulated androgen production in women undergoing in vitro fertilization","volume":"100","author":"Gervais","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2265.1997.2321049.x","article-title":"Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome","volume":"47","author":"Gilling-Smith","year":"1997","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"key\n\t\t\t\t20180207052726_r40","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0026-0495(03)00104-5","article-title":"Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome","volume":"52","author":"Glueck","year":"2003","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t20180207052726_r41","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2337\/dc11-1583","article-title":"Abdominal superficial subcutaneous fat: A putative distinct protective fat subdepot in type 2 diabetes","volume":"35","author":"Golan","year":"2012","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20180207052726_r42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1467-789X.2003.00091.x","article-title":"Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders","volume":"4","author":"Goossens","year":"2003","journal-title":"Obes. Rev."},{"key":"key\n\t\t\t\t20180207052726_r43","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1172\/JCI115395","article-title":"Expression of AT2 receptors in the developing rat fetus","volume":"88","author":"Grady","year":"1991","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20180207052726_r44","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1210\/endo-122-5-2034","article-title":"Insulin as a regulator of androgen biosynthesis by cultured rat ovarian cells: Cellular mechanism(s) underlying physiological and pharmacological hormonal actions","volume":"122","author":"Hernandez","year":"1988","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20180207052726_r45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1507\/endocrj.53.1","article-title":"Signaling crosstalk angiotensin II receptor subtypes and insulin","volume":"53","author":"Horiuchi","year":"2006","journal-title":"Endocr. J."},{"key":"key\n\t\t\t\t20180207052726_r46","first-page":"4103","article-title":"Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: Evidence from GnRH agonist and human chorionic gonadotropin stimulation testing","volume":"81","author":"Iba\u00f1ez","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r47","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/01.hjh.0000160198.05416.72","article-title":"Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes","volume":"23","author":"Jandeleit-Dahm","year":"2005","journal-title":"J. Hypertens."},{"key":"key\n\t\t\t\t20180207052726_r48","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3325\/cmj.2007.6.864","article-title":"Decreased androgen levels and improved menstrual pattern after angiotensin II receptor antagonist telmisartan treatment in four hypertensive patients with polycystic ovary syndrome: Case series","volume":"48","author":"Jensterle","year":"2007","journal-title":"Croat. Med. J."},{"key":"key\n\t\t\t\t20180207052726_r49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2012.03.005","article-title":"Role of renin-angiotensin-aldosterone system in adipose tissue dysfunction","volume":"378","author":"Jing","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"key\n\t\t\t\t20180207052726_r50","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.fertnstert.2011.01.154","article-title":"Associations between free fatty acids, cumulus oocyte complex morphology and ovarian function during in vitro fertilization","volume":"95","author":"Jungheim","year":"2011","journal-title":"Fertil. Steril."},{"key":"key\n\t\t\t\t20180207052726_r51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2004-830540","article-title":"Role of ovary and adrenal glands in hyperandrogenemia in patients with polycystic ovary syndrome","volume":"113","author":"Kamel","year":"2005","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"key\n\t\t\t\t20180207052726_r52","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0015-0282(99)00118-1","article-title":"Alternate pathway 17,20-lyase enzyme activity in the adrenals is enhanced in patients with polycystic ovary syndrome","volume":"71","author":"Kele\u015ftimur","year":"1999","journal-title":"Fertil. Steril."},{"key":"key\n\t\t\t\t20180207052726_r53","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/mol.106.028902","article-title":"Pioglitazone inhibits androgen production in NCI-H295R Cells by regulating gene expression of CYP17 and HSD3B2","volume":"71","author":"Kempna","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"key\n\t\t\t\t20180207052726_r54","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1210\/rp.56.1.239","article-title":"Peroxisome proliferator-activated receptors: From genes to physiology","volume":"56","author":"Kliewer","year":"2001","journal-title":"Recent Prog. Horm. Res."},{"key":"key\n\t\t\t\t20180207052726_r55","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1093\/humrep\/16.12.2546","article-title":"Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: Effect of metformin","volume":"16","author":"Koivunen","year":"2001","journal-title":"Hum. Reprod."},{"key":"key\n\t\t\t\t20180207052726_r56","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/S0002-9378(87)80246-6","article-title":"Insulin resistance and abnormal ovarian responses to human chorionic gonadotropin in chronically anovulatory women","volume":"157","author":"Kustin","year":"1987","journal-title":"Am. J. Obstet. Gynecol."},{"key":"key\n\t\t\t\t20180207052726_r57","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1210\/en.2014-1185","article-title":"Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome","volume":"155","author":"Leblanc","year":"2014","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20180207052726_r58","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r59","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","author":"Legro","year":"2001","journal-title":"Am. J. Med."},{"issue":"23(Suppl. B","key":"key\n\t\t\t\t20180207052726_r60","doi-asserted-by":"crossref","first-page":"23B","DOI":"10.1016\/S0828-282X(07)71007-3","article-title":"Hypertriglyceridemic waist: A useful screening phenotype in preventive cardiology?","author":"Lemieux","year":"2007","journal-title":"Can. J. Cardiol."},{"key":"key\n\t\t\t\t20180207052726_r61","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/humrep\/12.7.1416","article-title":"A pilot study of the human chorionic gonadotrophin test for ovarian hyperandrogenism","volume":"12","author":"Levrant","year":"1997","journal-title":"Hum. Reprod."},{"key":"key\n\t\t\t\t20180207052726_r62","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1210\/edrv.23.2.0461","article-title":"Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes","volume":"23","author":"Lewis","year":"2002","journal-title":"Endocr. Rev."},{"key":"key\n\t\t\t\t20180207052726_r63","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.bone.2006.04.008","article-title":"Surface-specific effects of a PPAR\u03b3 agonist, darglitazone, on bone in mice","volume":"39","author":"Li","year":"2006","journal-title":"Bone"},{"key":"key\n\t\t\t\t20180207052726_r64","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/humupd\/dms030","article-title":"Overweight, obesity and central obesity in women with polycystic ovary syndrome: A systematic review and meta-analysis. Hum","volume":"18","author":"Lim","year":"2012","journal-title":"Reprod. Update"},{"key":"key\n\t\t\t\t20180207052726_r65","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1210\/jc.2008-0714","article-title":"Intravenous lipid and heparin infusion-induced elevation in free fatty acids and triglycerides modifies circulating androgen levels in women: A randomized, controlled trial","volume":"93","author":"Mai","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r66","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.tcm.2006.03.008","article-title":"Insulin resistance and cardiovascular risk: New insights from molecular and cellular biology","volume":"16","author":"Morisco","year":"2006","journal-title":"Trends Cardiovasc. Med."},{"key":"key\n\t\t\t\t20180207052726_r67","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/en.2003-0329","article-title":"Insulin Augmentation of 17\u03b1-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1\/2 in human ovarian theca cells","volume":"145","author":"Munir","year":"2004","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20180207052726_r68","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/mend.13.6.0311","article-title":"Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries","volume":"13","author":"Nelson","year":"1999","journal-title":"Mol. Endocrinol."},{"key":"key\n\t\t\t\t20180207052726_r69","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/me.2004-0178","article-title":"Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome","volume":"19","author":"Nelson-Degrave","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"key\n\t\t\t\t20180207052726_r70","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r71","doi-asserted-by":"crossref","first-page":"E2269","DOI":"10.1210\/jc.2013-3942","article-title":"Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization","volume":"99","author":"Niu","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r72","doi-asserted-by":"crossref","first-page":"e48387","DOI":"10.1371\/journal.pone.0048387","article-title":"Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPAR\u03b3 activation","volume":"7","author":"Ohshima","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180207052726_r73","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.mce.2008.12.011","article-title":"Angiotensin II and the development of insulin resistance: Implications for diabetes","volume":"302","author":"Olivares-Reyes","year":"2009","journal-title":"Mol. Cell. Endocrinol."},{"key":"key\n\t\t\t\t20180207052726_r74","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1210\/jcem.87.3.8305","article-title":"Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome","volume":"87","author":"Palmert","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r75","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrcardio.2010.85","article-title":"Novel therapeutic targets for hypertension","volume":"7","author":"Paulis","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"key\n\t\t\t\t20180207052726_r76","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1210\/endo-128-4-1947","article-title":"Biochemical properties of the ovarian granulosa cell type 2-angiotensin II receptor","volume":"128","author":"Pucell","year":"1991","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20180207052726_r77","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20180207052726_r78","first-page":"1295","article-title":"The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome","volume":"76","author":"Rittmaster","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r79","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180207052726_r80","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1262-3636(07)70147-7","article-title":"Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms","volume":"30","author":"Scheen","year":"2004","journal-title":"Diabetes Metab."},{"key":"key\n\t\t\t\t20180207052726_r81","first-page":"2067","article-title":"Early expression of all the components of the renin-angiotensin-system in human development","volume":"149","author":"Sch\u00fctz","year":"1996","journal-title":"Am. J. Pathol."},{"key":"key\n\t\t\t\t20180207052726_r82","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/ki.1995.156","article-title":"Ontogeny of angiotensin II type 2 (AT2) receptor mRNA in the rat","volume":"47","author":"Shanmugam","year":"1995","journal-title":"Kidney Int."},{"key":"key\n\t\t\t\t20180207052726_r83","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejogrb.2013.11.011","article-title":"Hypertension in women with polycystic ovary syndrome: Prevalence and associated cardiovascular risk factors","volume":"173","author":"Shi","year":"2014","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"key\n\t\t\t\t20180207052726_r84","doi-asserted-by":"crossref","first-page":"E197","DOI":"10.1152\/ajpendo.00149.2012","article-title":"Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat\/high-fructose diet-induced insulin resistance in rats","volume":"304","author":"Shum","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r85","doi-asserted-by":"crossref","first-page":"e2466","DOI":"10.1371\/journal.pone.0002466","article-title":"Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome","volume":"3","author":"Skov","year":"2008","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180207052726_r86","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1470320309347791","article-title":"The past, present and future of angiotensin II type 2 receptor stimulation","volume":"11","author":"Steckelings","year":"2010","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"key\n\t\t\t\t20180207052726_r87","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0895-4356(98)00010-9","article-title":"Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: Results of a case-control study","volume":"51","author":"Talbott","year":"1998","journal-title":"J. Clin. Epidemiol."},{"key":"key\n\t\t\t\t20180207052726_r88","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1006\/bbrc.1995.1229","article-title":"Characterization of angiotensin II receptor type 2 during differentiation and apoptosis of rat ovarian cultured granulosa cells","volume":"207","author":"Tanaka","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"key\n\t\t\t\t20180207052726_r89","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.5694\/mja11.10915","article-title":"Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline","volume":"195","author":"Teede","year":"2011","journal-title":"Med. J. Aust."},{"key":"key\n\t\t\t\t20180207052726_r90","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.fertnstert.2012.08.025","article-title":"Adipose tissue insulin resistance in peripubertal girls with first-degree family history of polycystic ovary syndrome","volume":"98","author":"Trottier","year":"2012","journal-title":"Fertil. Steril."},{"key":"key\n\t\t\t\t20180207052726_r91","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jcem.87.3.8308","article-title":"Troglitazone, an insulin-sensitizing thiazolidinedione, represses combined stimulation by LH and insulin of de novo androgen biosynthesis by thecal cells in vitro","volume":"87","author":"Veldhuis","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r92","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1172\/JCI119424","article-title":"Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids","volume":"99","author":"Vidal-Puig","year":"1997","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20180207052726_r93","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1210\/jc.2005-1494","article-title":"Heritability of polycystic ovary syndrome in a Dutch twin-family study","volume":"91","author":"Vink","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r94","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/eje.0.1440619","article-title":"The effects of long-term metformin treatment on adrenal and ovarian steroidogenesis in women with polycystic ovary syndrome","volume":"144","author":"Vrb\u00edkov\u00e1","year":"2001","journal-title":"Eur. J. Endocrinol."},{"key":"key\n\t\t\t\t20180207052726_r95","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/edrv.21.6.0415","article-title":"Subcutaneous and visceral adipose tissue: Their relation to the metabolic syndrome","volume":"21","author":"Wajchenberg","year":"2000","journal-title":"Endocr. Rev."},{"key":"key\n\t\t\t\t20180207052726_r96","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1021\/jm049715t","article-title":"Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist","volume":"47","author":"Wan","year":"2004","journal-title":"J. Med. Chem."},{"key":"key\n\t\t\t\t20180207052726_r97","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tem.2006.01.003","article-title":"Human ovarian theca cells in culture","volume":"17","author":"Wickenheisser","year":"2006","journal-title":"Trends Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r98","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1016\/S0002-9343(99)80056-4","article-title":"Obesity, lipids, cardiovascular risk, and androgen excess","volume":"98","author":"Wild","year":"1995","journal-title":"Am. J. Med."},{"key":"key\n\t\t\t\t20180207052726_r99","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1210\/jcem.80.12.8530637","article-title":"Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor","volume":"80","author":"Willis","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r100","first-page":"302","article-title":"Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries","volume":"81","author":"Willis","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key\n\t\t\t\t20180207052726_r101","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1083-3188(98)70115-9","article-title":"Human chorionic gonadotropin stimulation to assess for ovarian hyperandrogenism","volume":"11","author":"Witchel","year":"1998","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"key\n\t\t\t\t20180207052726_r102","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0015-0282(03)01007-0","article-title":"Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome","volume":"80","author":"Wu","year":"2003","journal-title":"Fertil. Steril."},{"key":"key\n\t\t\t\t20180207052726_r103","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","article-title":"Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1","volume":"98","author":"Wu","year":"1999","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180207052726_r104","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1210\/endo.137.4.8625890","article-title":"Angiotensin II induces ovulation and oocyte maturation in rabbit ovaries via the AT2 receptor subtype","volume":"137","author":"Yoshimura","year":"1996","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20180207052726_r105","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1073\/pnas.92.23.10619","article-title":"Serine phosphorylation of human P450c17 increases 17,20-lyase activity: Implications for adrenarche and the polycystic ovary syndrome","volume":"92","author":"Zhang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Journal of Animal Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jas\/article-pdf\/94\/5\/1803\/23766297\/1803.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T09:25:57Z","timestamp":1748856357000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jas\/article\/94\/5\/1803\/4701489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,1]]},"references-count":105,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5,1]]}},"URL":"https:\/\/doi.org\/10.2527\/jas.2015-0089","relation":{},"ISSN":["0021-8812","1525-3163"],"issn-type":[{"value":"0021-8812","type":"print"},{"value":"1525-3163","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,5]]},"published":{"date-parts":[[2016,5,1]]}}}